This content is exclusively provided by FAO / FAOLEX

Regulation No. 699 the Import, Wholesale Distribution, and Brokerage of Medicinal Products.

Country
Type of law
Regulation
Date of original text
Date of latest amendment
Source

Abstract
This Regulation concerns the import, wholesale distribution, and export of medicinal products and active substances intended for humans or animals, unless otherwise stated. A medicinal product refers to medicines that have marketing authorization in Iceland, medicines permitted for use under a special authorization granted by the Icelandic Medicines Agency, investigational medicinal products for clinical drug research on humans, and prescription drugs. This includes medicinal products, veterinary medicinal products, herbal medicinal products, and premixes for medicated feedingstuffs, among others. The Regulation contains detailed rules on the import and wholesale distribution of medicines; registration of importers and distributors of active substances; vaccines and medicines made from human blood or plasma; storage and transport of medicines; record-keeping obligations; notification of counterfeit medicines; among others.
Notes
Consolidated version as last amended by Regulation No. 359 of 2024.
Repealed
No
Source language

English

Legislation Amendment
No
Original title
Reglugerð um innflutning, heildsöludreifingu og miðlun lyfja.